@realnicktrigili

2 posts audited · 11 claims analysed

Instagram profile

Science evidence grade

9%Very low evidence grade

Based on 11 claims across 2 audits

SupportedOverstatedMisleadingNo Evidence

1

Supported

9%

0

Overstated

0%

0

Misleading

0%

10

No Evidence

91%

Share this evidence grade

Claim-level evidence grades — not a character judgment. Methodology · Right of reply · Leaderboards

What @realnicktrigili claims actually are

We separate claims into three buckets: backed by evidence, factually incorrect, and grey — like animal-only findings sold as human fact (e.g. BPC-157 “fixes Achilles” from rat studies).

Evidence-based

9%

1 claim

Claims that align with published human or clinical evidence at the stated strength.

Ex: “Semaglutide can reduce body weight in adults with obesity” — supported by large RCTs.

Factually incorrect

0%

0 claims

Claims that conflict with the evidence, invent certainty, or omit critical safety/context in a misleading way.

Ex: “Peptides have no side effects” — contradicts known adverse-event profiles.

Grey / overstated

91%

10 claims

Plausible direction but wrong certainty — animal-only data sold as human fact, dose/effect overstated, or no adequate published support yet.

Ex: “BPC-157 fixes Achilles tears” — often rests on rodent tendon models, not proven human Achilles repair trials.

Evidence mix

Share of audited claims in each bucket

Loading…
BackedIncorrectGrey

Verdict detail

Grey splits into overstated (wrong certainty) vs no published support

Loading…

Claims over time

Stacked by bucket as audits land — plus the running evidence grade

Loading…

Gold line = running science evidence grade (Supported + ½ Overstated ÷ total claims).

Audit history(2 posts)

Post thumbnail
Supported
Audited Jul 5, 2026·26 days ago·View source

Weight loss is NOT the only goal

All five claims lack direct peer-reviewed evidence, registered clinical trials, or accessible PubMed abstracts supporting their specific assertions about RETA. While internal PeptIQ context suggests retatrutide has a documented triple-receptor mechanism and clinical weight-loss data exists, the creator's claims about metabolic regulation, gastric emptying, appetite control, energy stability, and consistent fat loss remain unsupported by materials provided. To validate these claims, direct citations to published human trials or peer-reviewed studies would be necessary.

Post thumbnail
No Evidence
Audited Feb 28, 2026·5 months ago·View source

Stop falling for this nonsense thinking peps are a quick fix

None of the claims about GHKCU could be substantiated with current scientific research. More rigorous scientific investigation is needed to validate these potential therapeutic claims.

Audit another post from @realnicktrigili

Paste their social post link to add a new audit

New audit